RA CAPITAL MANAGEMENT, L.P. - 27 Mar 2024 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
NKTX
Transactions as of
27 Mar 2024
Net transactions value
+$60,000,010
Form type
4
Filing time
29 Mar 2024, 17:38:04 UTC
Previous filing
27 Mar 2024
Next filing
04 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTX Common Stock Purchase $30,000,000 +3,000,000 +43% $10.00 10,050,818 27 Mar 2024 See footnotes F1, F2
holding NKTX Common Stock 754,311 27 Mar 2024 See footnotes F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTX Pre- Funded Warrants (Right to Buy) Purchase $30,000,010 +3,000,031 $10.00 3,000,031 27 Mar 2024 Common Stock 3,000,031 $0.000100 See footnote F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F2 Held directly by the Fund.
F3 Held directly by the Nexus Fund.
F4 The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.

Remarks:

Dr. Zach Scheiner, a Principal of the Adviser, serves on the Issuer's board of directors.